If a CMS auditor walked into your rehab clinic today and asked you to prove the value of every patient you treated last quarter — could you? Most rehab professionals would pause. Not because they are not delivering excellent care, but because they are not measuring and documenting that care in the language value-based care programs actually score.

That gap is no longer a future problem. The CMS Final Rule 2025 tightened reimbursement while expanding quality reporting obligations. The Skilled Nursing Facility Value-Based Purchasing program expanded from one measure to four, effective October 1, 2025. And patient adherence — long treated as a scheduling inconvenience — has become a direct financial liability under MIPS, PDPM, and bundled alternative payment models. For rehab and physical therapy practices operating in 2026, the window for passive preparation officially closed.

What Is Value-Based Care in Healthcare -And Why Rehab Is Ground Zero

At its core, value-based care is a healthcare reimbursement model that ties payment to patient outcomes rather than the volume of services provided. The foundational definition, articulated by Porter and Lee in Academic Medicine (2021), frames value as measured patient outcomes relative to the cost of achieving those outcomes. That word — “measured” — is carrying enormous weight. Without measurement, there is no documented value. Without documented value, there is no reimbursement advantage.

For rehab and physical therapy practices, this shift is structural, not incremental. Value-based care in physical therapy means that your MIPS quality score, your PDPM MDS accuracy in skilled nursing, and your episode cost performance in bundled payment models are all expressions of the same underlying question: how much measurable patient improvement are you generating per dollar spent?

CMS has operationalized this through three interconnected VBC layers that every rehab clinic now navigates whether they know it or not. Quality reporting programs — MIPS, the Rehabilitative Support for Musculoskeletal Care MVP (M1370), and the SNF VBP program — create financial stakes tied directly to outcome data. Alternative payment models, including BPCI-A, ACO REACH, and the forthcoming ACCESS Model for chronic MSK pain launching July 1, 2026, create shared savings or penalty exposure based on episode cost performance.

CMS Final Rule 2025: What Actually Changed for Rehab Clinics

On November 1, 2024, CMS released the Calendar Year 2025 Medicare Physician Fee Schedule Final Rule. For rehab providers, the rule delivered continued reimbursement pressure alongside two meaningful administrative wins that will affect clinic operations for years. Understanding both sides of this equation is essential for accurate financial planning in 2026 and beyond.

The conversion factor dropped to $32.35 — down 2.83% from $33.29 in 2024 and the fifth consecutive annual reduction. For a practice billing $500,000 annually in Medicare Part B, this translates to approximately $14,000 in equivalent lost revenue without operational adjustment. Looking ahead to 2026, the proposed conversion factor rises to $33.42 for non-APM participants and $33.85 for qualifying APM participants — the first proposed increase in five years.

The administrative victories deserve equal attention. CMS finalized general supervision for PTAs in private practice outpatient settings, replacing the prior direct supervision requirement. APTA described this as leveling the playing field: PTs can now treat other patients or work off-site while a PTA sees patients in the same clinic. Simultaneously, CMS streamlined plan of care certification: physician signature is no longer required when a written referral is on file and the POC is transmitted within 30 days of the initial evaluation. This eliminates one of the most persistent claim-delay and denial triggers in outpatient PT billing.

‍

Patient Adherence: The Invisible Metric Wrecking Your VBC Performance

Patient adherence is the metric most rehab clinics underestimate — and the one that generates the most compounded financial damage in a value-based care environment. The research tells a clarifying story.

As much as 80% of information given to patients during a clinical visit is immediately forgotten, including key plan of care details (Kessels, cited in PMC 2025 RTM retrospective study). Up to 70% of patients are non-compliant with prescribed home exercise programs. Thomas and Shaver et al., writing in Musculoskeletal Science and Practice (2025), documented no-show and cancellation rates ranging from 10% to 73% across outpatient settings. A 2024 study in JOSPT Open found that among patients with chronic pain, the self-discharge rate reached 55%, with no-show frequency strongly predicting premature dropout.

In a fee-for-service environment, this was primarily a scheduling and revenue problem. In a value-based care environment, adherence failure creates a triple financial penalty that operates simultaneously across MIPS, APM, and PDPM exposure. First, incomplete care plans produce incomplete functional outcome data, which creates MIPS quality submission gaps that directly lower quality scores and expose practices to payment adjustments of up to ±9% of Medicare Part B revenue.

Second, premature dropout followed by readmission or care escalation inflates cost-per-episode and creates APM penalty exposure under bundled payment models.

Third, the MIPS Cost Category — which carries 30% weight in the overall composite score starting in 2025 — is calculated by CMS from claims data. Fragmented, incomplete episodes signal inefficiency regardless of the quality of care actually delivered during the completed visits.

The operational implication is direct: adherence is now a trackable, reportable, and financially consequential VBC metric. Practices that build proactive monitoring infrastructure — RTM-enabled check-ins, automated reminders, engagement alerts triggered by early absence patterns — generate a structural adherence advantage that compounds across MIPS quality scores, APM episode cost performance, and PDPM readmission risk simultaneously.

Value-Based Care in Skilled Nursing: The SNF VBP Expansion Nobody’s Ready For

For six consecutive years, the Skilled Nursing Facility Value-Based Purchasing program operated on a single measure. Incentive payments and financial penalties were determined entirely by the SNF 30-Day All-Cause Readmission Measure. That era ended on October 1, 2025.

The FY 2026 SNF PPS Final Rule (CMS-1827-F), issued July 31, 2025, expanded the SNF VBP program from one measure to four: all-cause readmissions, healthcare-associated infections, nursing staff turnover, and nursing hours per resident day. For FY 2027, the program expands again to eight measures, adding discharge function score, hospitalization rate for long-stay residents, and the new SNF Within-Stay Potentially Preventable Readmission (WS PPR) measure — which tracks readmissions occurring during the SNF stay itself rather than only at post-discharge.

The financial mechanics are significant. CMS withholds 2% of all Medicare FFS Part A payments to fund the SNF VBP program, then redistributes between 50% and 70% of that withhold as incentive payments to high performers. Estimated SNF VBP reductions for FY 2026 total $208.36 million across the industry — applied in addition to the 3.2% rate increase ($1.16 billion in additional aggregate payments) finalized for the same year.

‍

High-performing SNFs receive both the rate increase and incentive payment returns; underperforming ones absorb the withhold as a net reduction.

The PDPM changes that accompany this rule compound the compliance challenge. CMS finalized 34 ICD-10 code mapping changes for FY 2026, removing conditions including diabetes without complications, obesity, anorexia, and hypoglycemia from primary diagnosis eligibility for skilled SNF stays. SNFs that have relied on these diagnoses as PDPM primary codes face payment reclassification risk immediately and must audit their MDS documentation practices.

For physical therapists in skilled nursing settings, this expansion is both a compliance obligation and a clinical opportunity. PT teams are directly responsible for the functional documentation that determines PDPM payment accuracy. They are also the clinical team most capable of moving the metrics that now drive SNF VBP performance: reducing readmissions through progressive rehabilitation, improving discharge functional scores through goal-directed therapy planning, and preventing within-stay readmissions through real-time clinical monitoring. The FY 2027 Discharge Function Score measure — the most PT-specific VBP metric in SNF history — will directly link PT documentation quality to facility incentive payment performance.

What Forward-Thinking Rehab Clinics Are Doing Differently in 2026

The practices performing best in value-based care programs share a common infrastructure, not a common philosophy. They have built systems that generate VBC compliance data as a byproduct of normal clinical documentation rather than as a separate administrative task added after care is delivered.

In practice, this means functional outcome scores are embedded into intake and discharge workflows so FOTO, PROMIS, or OPTIMAL data is captured at the clinical moment rather than reconstructed before a MIPS submission deadline. It means adherence is visible before it becomes a problem: RTM-enabled practices flag at-risk patients after the first missed appointment, not after a self-discharge that has already created a MIPS quality gap and an APM cost exposure, and it means understanding which value-based care programs actually apply to each specific practice setting, because MIPS, SNF VBP, and PDPM operate on different data requirements, different performance periods, and different financial stakes — and optimizing for the wrong metrics is a structural error that no amount of clinical excellence can correct.

Spry’s AI-powered platform integrates outcomes measurement, MIPS quality tracking, PDPM documentation accuracy, and denial prevention analytics into a single clinical-administrative workflow. When the infrastructure is right, VBC compliance generates itself as a byproduct of the care you are already delivering.

Conclusion: Measure What Matters Before CMS Measures It for You

Value-based care in healthcare is not a future state for rehab clinics — it is the operating environment of 2026. The CMS Final Rule 2025 extended a five-year pattern of reimbursement pressure while delivering real administrative relief and expanding quality reporting obligations. The SNF VBP program tripled its measure set this fiscal year. Patient adherence failures are simultaneously costing practices MIPS quality points, APM cost performance, and PDPM readmission risk. Each of these changes is already in effect.

The practices that navigate this successfully are not the ones that know the most about VBC theory. They are the ones that have built measurement systems — for outcomes documentation, adherence monitoring, and real-time metric tracking — that make compliance data visible when it can still be acted on. The 2030 accountability deadline will arrive regardless. The question is whether your clinic’s infrastructure will be ready.

Frequently Asked Questions

1. What is value-based care in healthcare and how does it differ from fee-for-service?

Value-based care ties payment to measurable patient outcomes relative to the cost of delivering them. Fee-for-service pays per billable service unit regardless of patient outcome. In VBC, a clinic that delivers better outcomes at lower cost earns more; one that generates more visits without proportional outcome improvement earns less.

2. Which value-based care programs apply specifically to physical therapy practices?

The primary programs affecting PT practices are MIPS with the MSK MVP (M1370) as the recommended outpatient pathway, the SNF VBP program for PTs working in skilled nursing, and bundled APMs including BPCI-A and the ACCESS Model for chronic MSK pain launching July 1, 2026.

3. How does the CMS Final Rule 2025 specifically affect PT reimbursement?

The 2025 rule reduced the Medicare conversion factor to $32.35 (a 2.83% cut), raised the therapy threshold to $2,410, eliminated automatic MIPS reweighting for PTs, and delivered two major compliance wins: general PTA supervision in outpatient private practice and streamlined plan of care certification. Each change has direct implications for revenue planning and MIPS strategy.

4. Why does patient adherence matter for value-based care performance metrics?

Poor adherence creates three compounding VBC penalties simultaneously: MIPS quality submission gaps from incomplete outcome data, inflated episode costs from premature dropout and subsequent care escalation, and APM penalty exposure when self-discharged patients require readmission within the same bundle.

5. How does the SNF VBP expansion in FY 2026 affect physical therapists in skilled nursing?

PTs now directly influence at least three of the four FY 2026 VBP measures through functional rehabilitation (reducing readmissions), early mobility protocols (reducing HAIs), and precise MDS documentation (supporting PDPM accuracy). By FY 2027, the Discharge Function Score will make PT documentation quality a direct driver of facility incentive payment performance.

‍